This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olson, L. K. Articles by Poitout, V. Search for Related Content PubMed PubMed Citation Articles by Olson, L. K. Articles by Poitout, V.

Glucose Rapidly and Reversibly Decreases INS-1 Cell Insulin Gene Transcription via Decrements in STF-1 and C1 Activator Transcription Factor Activity

Department of Physiology (L.K.O., J.Q.) Michigan State University East Lansing, Michigan 48824-1101
INSERM U341 (V.P.) Service de Diabetologie, Hôtel Dieu 75004 Paris, France

We have reported that chronic exposure of HIT-T15 cells to supraphysiological concentrations of glucose over many months leads to decreased insulin gene transcription and decreased binding activities of two ß-cell-specific transcription factors, STF-1 and C1 activators, and have postulated that these events may provide a mechanism for glucose toxicity on ß-cell function. We now report that culturing the highly differentiated rat insulinoma cell line, INS-1, in glucose concentrations above 8.0 mM caused a marked decrease in insulin mRNA levels within 24 h. The decrease in insulin mRNA levels was reversed by further incubation of the cells in 4.0 mM glucose. Transient transfection of a chloramphenicol acetyltransferase reporter gene regulated by the 5'-regulatory sequences of the human insulin gene showed that elevated glucose concentrations caused a large decrease in insulin gene promoter activity. The decrease in insulin gene promoter activity was associated with reductions in the binding activities of both STF-1 and C1 activator, and these were partially reversed by lowering the glucose concentration. The decrease in STF-1 binding activity was associated with decreased STF-1 mRNA and occurred independently of changes in STF-1 promoter activity, suggesting a posttranscriptional regulatory mechanism. Furthermore, the decrease in insulin gene expression was found to occur independently of changes in cell proliferation. We conclude that physiologically relevent elevations in glucose can reversibly diminish insulin gene transcription by reducing the expression and/or binding activity of two critical ß-cell transcription factors.

This article has been cited by other articles:

				X. Zhang, W. Yong, J. Lv, Y. Zhu, J. Zhang, F. Chen, R. Zhang, T. Yang, Y. Sun, and X. Han Inhibition of Forkhead Box O1 Protects Pancreatic {beta}-Cells against Dexamethasone-Induced Dysfunction Endocrinology, September 1, 2009; 150(9): 4065 - 4073. [Abstract] [Full Text] [PDF]

				C. D. Green, D. B. Jump, and L. K. Olson Elevated Insulin Secretion from Liver X Receptor-Activated Pancreatic {beta}-Cells Involves Increased de Novo Lipid Synthesis and Triacylglyceride Turnover Endocrinology, June 1, 2009; 150(6): 2637 - 2645. [Abstract] [Full Text] [PDF]

				L. Zhang, E. Lai, T. Teodoro, and A. Volchuk GRP78, but Not Protein-disulfide Isomerase, Partially Reverses Hyperglycemia-induced Inhibition of Insulin Synthesis and Secretion in Pancreatic {beta}-Cells J. Biol. Chem., February 20, 2009; 284(8): 5289 - 5298. [Abstract] [Full Text] [PDF]

				V. Poitout and R. P. Robertson Glucolipotoxicity: Fuel Excess and {beta}-Cell Dysfunction Endocr. Rev., May 1, 2008; 29(3): 351 - 366. [Abstract] [Full Text] [PDF]

				M. Dubois, P. Vacher, B. Roger, D. Huyghe, B. Vandewalle, J. Kerr-Conte, F. Pattou, N. Moustaid-Moussa, and J. Lang Glucotoxicity Inhibits Late Steps of Insulin Exocytosis Endocrinology, April 1, 2007; 148(4): 1605 - 1614. [Abstract] [Full Text] [PDF]

				K.-G. Park, K.-M. Lee, H.-Y. Seo, J.-H. Suh, H.-S. Kim, L. Wang, K.-C. Won, H.-W. Lee, J.-Y. Park, K.-U. Lee, et al. Glucotoxicity in the INS-1 Rat Insulinoma Cell Line Is Mediated by the Orphan Nuclear Receptor Small Heterodimer Partner Diabetes, February 1, 2007; 56(2): 431 - 437. [Abstract] [Full Text] [PDF]

				M. Ubeda, J. M. Rukstalis, and J. F. Habener Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity J. Biol. Chem., September 29, 2006; 281(39): 28858 - 28864. [Abstract] [Full Text] [PDF]

				D. Z. Ye, M.-H. Tai, K. D. Linning, C. Szabo, and L. K. Olson MafA Expression and Insulin Promoter Activity Are Induced by Nicotinamide and Related Compounds in INS-1 Pancreatic {beta}-Cells Diabetes, March 1, 2006; 55(3): 742 - 750. [Abstract] [Full Text] [PDF]

				D. Kawamori, H. Kaneto, Y. Nakatani, T.-a. Matsuoka, M. Matsuhisa, M. Hori, and Y. Yamasaki The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation J. Biol. Chem., January 13, 2006; 281(2): 1091 - 1098. [Abstract] [Full Text] [PDF]

				M. Amemiya-Kudo, J. Oka, T. Ide, T. Matsuzaka, H. Sone, T. Yoshikawa, N. Yahagi, S. Ishibashi, J.-i. Osuga, N. Yamada, et al. Sterol Regulatory Element-binding Proteins Activate Insulin Gene Promoter Directly and Indirectly through Synergy with BETA2/E47 J. Biol. Chem., October 14, 2005; 280(41): 34577 - 34589. [Abstract] [Full Text] [PDF]

				S. Mukherjee and S. E. Conrad c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells J. Biol. Chem., May 6, 2005; 280(18): 17617 - 17625. [Abstract] [Full Text] [PDF]

				M. F. Pino, D. Z. Ye, K. D. Linning, C. D. Green, B. Wicksteed, V. Poitout, and L. K. Olson Elevated Glucose Attenuates Human Insulin Gene Promoter Activity in INS-1 Pancreatic {beta}-Cells via Reduced Nuclear Factor Binding to the A5/Core and Z Element Mol. Endocrinol., May 1, 2005; 19(5): 1343 - 1360. [Abstract] [Full Text] [PDF]

				L. I. Jepeal, Y. Fujitani, M. O. Boylan, C. N. Wilson, C. V. Wright, and M. M. Wolfe Cell-Specific Expression of Glucose-Dependent-Insulinotropic Polypeptide Is Regulated by the Transcription Factor PDX-1 Endocrinology, January 1, 2005; 146(1): 383 - 391. [Abstract] [Full Text] [PDF]

				D. Kawamori, Y. Kajimoto, H. Kaneto, Y. Umayahara, Y. Fujitani, T. Miyatsuka, H. Watada, I. B. Leibiger, Y. Yamasaki, and M. Hori Oxidative Stress Induces Nucleo-Cytoplasmic Translocation of Pancreatic Transcription Factor PDX-1 Through Activation of c-Jun NH2-terminal Kinase Diabetes, December 1, 2003; 52(12): 2896 - 2904. [Abstract] [Full Text] [PDF]

				D. M. Kemp and J. F. Habener Insulinotropic Hormone Glucagon-Like Peptide 1 (GLP-1) Activation of Insulin Gene Promoter Inhibited by p38 Mitogen-Activated Protein Kinase Endocrinology, March 1, 2001; 142(3): 1179 - 1187. [Abstract] [Full Text] [PDF]

				C. E. Gleason, M. Gonzalez, J. S. Harmon, and R. P. Robertson Determinants of glucose toxicity and its reversibility in the pancreatic islet beta -cell line, HIT-T15 Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E997 - E1002. [Abstract] [Full Text] [PDF]

				L. Zhao, M. A. Cissell, E. Henderson, R. Colbran, and R. Stein The RIPE3b1 Activator of the Insulin Gene Is Composed of a Protein(s) of Approximately 43 kDa, Whose DNA Binding Activity Is Inhibited by Protein Phosphatase Treatment J. Biol. Chem., March 31, 2000; 275(14): 10532 - 10537. [Abstract] [Full Text] [PDF]

				R. Seijffers, O. Ben-David, Y. Cohen, A. Karasik, M. Berezin, C. B. Newgard, and S. Ferber Increase in PDX-1 Levels Suppresses Insulin Gene Expression in RIN 1046-38 Cells Endocrinology, July 1, 1999; 140(7): 3311 - 3317. [Abstract] [Full Text]

				C. Benes, M. P. Roisin, H. Van Tan, C. Creuzet, J.-i. Miyazaki, and R. Fagard Rapid Activation and Nuclear Translocation of Mitogen-activated Protein Kinases in Response to Physiological Concentration of Glucose in the MIN6 Pancreatic beta  Cell Line J. Biol. Chem., June 19, 1998; 273(25): 15507 - 15513. [Abstract] [Full Text] [PDF]